Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Shenzhen Edge Medical Co., Ltd. Class H ( (HK:2675) ).
Shenzhen Edge Medical Co., Ltd. has completed the full exercise of the over-allotment option in its Hong Kong global offering, with overall coordinators and international underwriters taking up an additional 4,158,300 H shares at HK$43.24 per share, equivalent to about 15% of the initial offer size, to facilitate delivery of shares to investors who agreed to delayed settlement. The stabilization period linked to the global offering has now ended, and the company has received listing approval for the over-allotment shares, with trading on the Main Board of the Hong Kong Stock Exchange expected to commence on 9 February 2026, underscoring strong demand for the issue and further broadening its shareholder base.
More about Shenzhen Edge Medical Co., Ltd. Class H
Shenzhen Edge Medical Co., Ltd. is a joint stock company incorporated in the People’s Republic of China with limited liability and listed in Hong Kong as a Class H share issuer, operating in the medical sector and raising capital through a global offering of H shares on the Main Board of the Stock Exchange of Hong Kong to support its business development and market expansion.
Average Trading Volume: 1,606,778
Current Market Cap: HK$24.31B
For detailed information about 2675 stock, go to TipRanks’ Stock Analysis page.